GC Therapeutics
Brett Losen is an experienced operations manager currently serving as the Senior Operations Manager at GC Therapeutics, where a focus on innovative synthetic biology and AI-driven cell programming is established. Prior experience includes a role as Operations Manager at Ally Therapeutics and a Senior Research Administrator at Brigham and Women's Hospital, specifically within the Division of Hematology. Brett has also held positions such as Lab Manager/Grants Coordinator in the Khademhosseini Laboratory, Operations Coordinator at Envision Experience, and provided administrative support at Dartmouth College. Educational qualifications include a Bachelor of Arts in Classical and Ancient Studies from Dartmouth College.
This person is not in any teams
GC Therapeutics
1 followers
GC Therapeutics Inc. (GCTx) uses synthetic biology to program patient-derived stem cells into any cell type with best-in-class efficiency (up to 10X), speed (up to 100X) and scalability. We dictate cells fates in a single step and have validated cells for many applications. We have also developed SuperCells™ by tailoring cells for specific diseases. The core technology of GCTx was conceived, invented and perfected in Professor George Church’s lab at Harvard Medical School. We are a group of passionate biologists and tissue engineers whose goal is to bring this breakthrough approach to patients.